| Document |
Document Title |
|
WO/2015/159225A1 |
An organometallic complex of a tridentate bis(phosphine)-carbodicarbene ligand and a transition metal, is described. In some embodiments the ligand has the structure of Formula (I): The complexes are useful in methods of making an allyli...
|
|
WO/2015/152273A1 |
This fluorine-containing compound is a nitrogen atom-containing perfluoroalkyl (meth)acrylate in which a plurality of straight-chain perfluoroalkyl groups having a carbon number of 6 or less have been bonded via a nitrogen atom, wherein ...
|
|
WO/2015/095346A1 |
This invention provides for a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1-R3, n, p, L1 and L2 are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cation...
|
|
WO/2015/091860A1 |
Use of at least one hydroxypropyltrialkylammonium derivative as deodorant agent The present invention relates to the use of one or more hydroxypropyltrialkylammonium derivatives of formula (I) as defined below for treating body odour, in...
|
|
WO/2015/091308A1 |
The present invention relates to a compound obtainable by the condensation of a polyol having 3-4 hydroxyl groups, adicarboxylic acid or a derivative thereof, an alkanolamine anda fatty acid, followed by reaction with an alkylating agent...
|
|
WO/2015/085245A1 |
Compounds and methods thereof for reducing cardiac arrhythmia are described. In particular, compounds generated by adding chemical groups that enhance the electron donor properties of RyR inhibitors may increase inhibitor potency and thu...
|
|
WO/2015/082588A1 |
The present invention relates to fumarate esters, e.g. for use as a medicament. In particular, the present invention relates to novel medicaments, preferably in the treatment and/or prevention of systemic diseases, autoimmune diseases, a...
|
|
WO/2015/019809A1 |
A bis(perfluoroether alkyl carboxylic acid) amino ester represented by the general formula {CnF2n+1O[CF(CF3)CF2O]aCF(CF3)COO(CH2)b}2NR, (wherein, R is a hydrogen atom, a C1-C12 alkyl group, an aryl group, or an aralkyl group, preferably ...
|
|
WO/2015/015211A1 |
Quaternary ammonium compounds and compositions comprising the compounds are disclosed. The compositions are valuable as gas hydrate inhibitors in the oil and gas exploration, recovery and processing industries. The compounds and composit...
|
|
WO/2015/005253A1 |
The compound represented in formula (Ia) is provided as a novel cationic lipid which forms lipid particles; also provided are a lipid particle containing said compound, a nucleic acid lipid particle containing said lipid particle, and a ...
|
|
WO/2014/207002A1 |
The present invention relates to a novel method for producing 2-(4-N,N-dialkylamino-2-hydroxybenzoyl) benzoates.
|
|
WO/2014/057414A9 |
The present invention relates to ketamine derivatives of the formula (I), pharmaceutical compositions comprising them, and methods for treating pain comprising administering them, and their use in the manufacture of medicaments for treat...
|
|
WO/2014/152494A1 |
The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
|
|
WO/2014/136906A1 |
Provided is a compound that, when included in a lubricating oil, can enhance longevity of shudder prevention, as well as gear-shift characteristics and torque transmission capacity, to satisfactory levels. Specifically provided is a comp...
|
|
WO/2014/115915A1 |
The present invention relates to a novel reactive mesogen compound, and a preparation method therefor, and more specifically, to: a novel reactive mesogen compound which has an intrinsic liquid crystal characteristic of having a molecula...
|
|
WO/2014/000629A9 |
The invention relates to hexahydropentaleno derivatives, the preparation method and use in medicine thereof, and in particular to hexahydropentaleno derivatives or stereo-isomers or pharmaceutically acceptable salts thereof as shown in g...
|
|
WO/2014/066361A1 |
The composition of the present invention related to a quaternary ammonium salt detergent and the use of such quaternary ammonium salt detergents in a fuel composition to reduce diesel injector deposits and remove or clean up existing dep...
|
|
WO/2014/066344A1 |
The composition of the present invention related to a quaternary ammonium salt detergent and the use of such quaternary ammonium salt detergents in a fuel composition to reduce diesel injector deposits and remove or clean up existing dep...
|
|
WO/2014/024207A1 |
The invention discloses a novel process for preparation of succinylcholine chloride via transesterification of succinic acid diester with choline chloride.
|
|
WO/2014/012832A1 |
The invention concerns a process for the preparation of 2-(3-N,N- diisopropylamino-l-phenylpropyl)-4-hydroxymethyl-phenol and its derivatives, particularly the corresponding (R) 4-trityloxymethyl derivative, useful as intermediate form i...
|
|
WO/2013/182023A1 |
The present invention provides a carbon fiber surface modifier, a modified carbon fiber, composites, and preparation methods therefor. The general structural formula of the carbon fiber surface modifier is as represented by formula (I): ...
|
|
WO/2013/170859A2 |
The present invention provides polymeric photoinitiators being co-polymers of photoinitiator monomers and at least one further monomer, as well as the photoinitiator monomers being intermediates in the preparation of such polymeric photo...
|
|
WO/2013/172466A1 |
A method for forming a negative pattern includes (i) forming a film from an actinic ray-sensitive or radiation-sensitive resin composition, (ii) exposing the film, and (iii) developing the exposed film by using a developer containing an ...
|
|
WO/2013/157450A1 |
The present invention is at least one type of polymer selected from a polyimide precursor containing a structure expressed by the following formula [I] as a side chain and polyimide and polyamide that are obtained through the imidization...
|
|
WO/2013/141262A1 |
Provided are: a liquid-crystal alignment agent that is easy to handle, has excellent coatability, and is capable of forming a liquid-crystal alignment film having photo-alignment properties for vertical alignment; a liquid-crystal alignm...
|
|
WO/2013/134869A1 |
The present description relates to compounds of Formula I (A+ X-), a diastereoisomer, an enantiomer, or a mixture thereof, pharmaceutical composition comprising same and uses thereof for gastrointestinal endoscopic and medical imaging ap...
|
|
WO/2013/129492A1 |
Provided are: an ion-binding salt having a reactive group that improves the weather resistance of a thermoplastic resin, said ion-binding salt being represented by chemical formula (1) or chemical formula (2); and a thermoplastic resin c...
|
|
WO/2013/117846A1 |
The invention relates to a cosmetic composition including at least one compound of formula (I), used alone or as part of a mixture, or one of the salts, hydrates, acetals, or hemiacetals thereof, where Y is an OR, NRR', or R group with R...
|
|
WO/2013/115040A1 |
Disclosed is a secondary battery, which is provided with an electrolyte solution and a negative electrode that contains a negative electrode active material, and wherein the negative electrode active material contains silicon and the ele...
|
|
WO/2013/109323A2 |
The present invention relates to topical trisodium diethylenetriamine pentaacetic acid (DTPA) prodrug formulations and methods of using the same.
|
|
WO/2013/104564A1 |
The present invention relates to a beta-amino acid ester, obtainable by the reaction of a di-acrylate of the general formula (I) with a diamine of the general formula (II), wherein R1 and R2 are organic groups containing no Zerewitinoff-...
|
|
WO/2013/065825A1 |
Provided is a cationic lipid expressed in the following formula (I), which facilitates introduction of a nucleic acid into a cell, a composition containing the cationic lipid and the nucleic acid, a method for introducing the nucleic aci...
|
|
WO/2013/064153A1 |
The present invention relates to novel depot formulations (prodrugs) comprising an immobility promoting unit linked via an ester to an active pharmaceutical ingredient, i.a. common NSAIDs. The novel depot formulations are suitable for in...
|
|
WO/2013/063127A1 |
The present application provides novel compounds and methods for preparing and using these compounds. These compounds are useful in treating pain, itch, overactive bladder and/or interstitial cystitis in patients by administering one or ...
|
|
WO/2013/050122A1 |
The present invention relates to polymer, homo- or copolymer or oligomer, which, when irradiated with polarised light orients perpendicular to the polarization direction of polarized actinic light, for the photoalignment of liquid crysta...
|
|
WO/2013/050121A1 |
The present invention relates to polymer, homo- or copolymer or oligomer for the photoalignment of liquid crystals, especially for the planar orientation of liquid crystals, comprising a main chain and a side chain, wherein the side chai...
|
|
WO/2013/045786A1 |
The present invention relates to the manufacture of dialkylaminoalkyl (meth)acrylate, in particular N,N-dimethylaminoethyl acrylate, by transesterification reaction of an alkyl (meth)acrylate with an amino alcohol, and the subject matter...
|
|
WO/2013/017467A1 |
The present invention relates to a copolymer for the photoalignment of liquid crystals comprising a photoreactive group as given below in formula (I), compositions thereof, and its use for optical and electro optical devices, especially ...
|
|
WO/2011/154854A9 |
The present invention regards an improved and industrially advantageous process for the preparation of the 2-hyaroxy-4-phenyl-3,4-dihydro-2H-chromen-6-yl-methanol intermediates, also called "feso chromenyl" and (R)-2-[3-(diisopropylamino...
|
|
WO/2012/159704A1 |
The present invention relates to crystal modifications of racemic (2R,S)- and enantiomerically pure (2R)- resp. (2S)-DOTAP chloride, to processes for the preparation thereof, and to the use thereof for the preparation of pharmaceutical c...
|
|
WO/2012/154945A2 |
Embodiments of the invention are directed to ONO pinccr ligands that can be in a trianionic, protonated or protonated equivalent form. The ONO pincer ligand can be combined with a transition metal comprising compound to form an ONO pince...
|
|
WO/2012/137047A1 |
The present invention relates to an improved process for the preparation of Fesoterodine and pharmaceutically acceptable salts thereof. The present invention particularly relates to a process for the preparation of fesoterodine and pharm...
|
|
WO/2012/133737A1 |
Provided are: a novel crosslinkable amine compound for producing a polymer membrane for separating carbon dioxide from another gas with high selectivity; a polymer membrane using the compound; a method for producing the polymer membrane;...
|
|
WO/2012/120143A1 |
The present invention relates to a composition that is suitable for use as a corrosion inhibitor to prevent corrosion, particularly on metallic devices for the recovery and transportation of hydrocarbons in oil production and processing....
|
|
WO/2012/098560A2 |
The present invention relates to novel and improved processes for the preparation of (r)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl
)phenylisobutyrate represented by the following structural formula-1 and its pharmaceutical...
|
|
WO/2012/093853A2 |
The present invention relates to a nonaqueous carbon dioxide absorber containing secondary alkanolamine and diol in which sterical hindrance is introduced. The carbon dioxide absorber according to the invention exhibits an excellent abso...
|
|
WO/2012/094622A2 |
Embodiments of the invention provide methods and materials for chemical cross-coupling reactions that utilize aryl alcohol derivatives as cross-coupling partners. Embodiments of the invention include methods for the amination of aryl sul...
|
|
WO/2012/076783A1 |
The invention concerns special (meth)acrylic monomers and relates more particularly to an improved process for preparing alkylaminoalkyl (meth)acrylates, in particular monoalkylaminoalkyl (meth)acrylates, in the presence of a catalyst se...
|
|
WO/2012/060396A1 |
The purpose of the present invention is to provide a novel trans-2-decenoic acid derivative and a pharmaceutically acceptable salt thereof, and a medicament containing the compound described above as an active component and having a neur...
|
|
WO/2012/041013A1 |
The present disclosure relates to polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same.
|
